ACN vs IT: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. ACN and IT share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined ACN and IT exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Accenture is a global professional services company that helps businesses, governments, and other organizations across more than 120 countries build digital infrastructure, optimize operations, and accelerate growth. The company operates across five major service areas: Strategy and Consulting, Technology Services, Operations, Industry X (engineering and manufacturing digitization), and Song (marketing and customer experience). It earns revenue through a mix of consulting engagements, managed services contracts, and increasingly fixed-price, outcome-based arrangements, with managed services growing faster at roughly 10% year over year as of Q2 FY2026. The company serves clients in virtually every major industry vertical, from financial services and health to communications and government, and generates the majority of its revenue outside North America.

Full ACN guide

Gartner, Inc. is the world's largest independent technology research and advisory firm, selling syndicated research, analyst access, benchmarking, and advisory relationships to IT, finance, HR, supply-chain, and other corporate leaders. It operates through three segments: Business and Technology Insights (formerly Research), which is nearly 100% subscription-based and is the profit engine; Conferences, the in-person events business that ran 53 conferences with over 83,000 attendees in 2025; and Consulting, a smaller project-based advisory arm. The economics are attractive because Insights carries high gross margins, high renewal rates, and predictable recurring revenue tied to contract value (the annualized value of subscription contracts), which management watches as the core growth metric.

Full IT guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• ACN drivers: Enterprise AI implementation at scale; Shift to recurring, outcome-based revenue.
• IT drivers: Subscription research and contract value; Cash generation and buybacks.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The most structural bear-case concern is AI cannibalization: if generative AI and agentic AI tools automate the coding, testing, documentation, and process management that make up a significant portion of Accenture's billable work, clients may require fewer hours per engagement, compressing revenue without a commensurate reduction in costs. For IT, the dominant risk is generative AI disintermediation: if free or cheaper AI tools can approximate the research and advice clients pay Gartner for, subscription demand and pricing power could erode, which is the primary reason the stock derated so sharply in 2026.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick ACN if you believe its drivers more; IT if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the ACN and IT guides.

ACN. Accenture's trailing P/E of roughly 10 to 13x represents a sharp discount to its own 5-year average of approximately 25x, a compression driven by AI cannibalization fears, federal spending headwinds, and a broader de-rating of large-cap professional services stocks rather than by any deterioration in underlying earnings, which have continued to grow. Operating margins near 17% and projected free cash flow of $10.8 billion to $11.5 billion in FY2026 reflect a business that is fundamentally sound and continuing to expand profitability. The elevated dividend yield above 3.5% (elevated because the share price has fallen roughly 38 to 40% over the prior 12 months) is now higher than Accenture's long-run average and is well covered by both earnings (roughly 52% payout ratio) and cash flows.

IT. Gartner traded around $140 in early-to-mid July 2026, down roughly two-thirds from a 52-week high above $400, which pushed the trailing P/E down near 13 against a five-year median above 30. The compression reflects fear that AI erodes the research franchise plus slowing contract-value growth, not a collapse in current profits, since cash flow and EPS actually rose. Analyst price targets clustered around the mid-$160s, implying the Street sees the selloff as partly overdone but keeps a cautious consensus.

Headline figures (approximate, 2026-06-27): ACN shows revenue (ttm) ~$72 billion, revenue (fy2025, ended aug 31 2025) ~$69.7 billion (+7% YoY), q3 fy2026 revenue ~$18.7 billion (+5.6% YoY), q3 fy2026 eps (diluted) ~$3.82 (vs $3.52 in Q3 FY2025); IT shows revenue (ttm) ~$6.5B, q1 2026 revenue ~$1.51B (-1.5% YoY), q1 2026 diluted eps ~$3.18 (+17% YoY), q1 2026 free cash flow ~$371M (+29% YoY).

ACN and IT are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined ACN and IT exposure against your real portfolio. It is not an investment adviser.